🕵️ Xeris Biopharma Holdings, Inc. ($XERS)
SEC insider & ownership activity, last 12 months · CIK 1867096 · every row links its SEC filing
Over the last 12 months insiders sold $5.7M with no open-market buying against it. Johnson John sold $1.9M in discretionary trades (Aug–Jun). 1 planned sale is pending, the largest $144K (Steven Pieper). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 10 sellers, $5.7M (27 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Johnson John | 0 | – | 3 | $1.9M | Jun 4, 2026 |
| Hecht Beth | 0 | – | 10 | $1.0M | Jul 1, 2026 |
| McCulloch Kevin | 0 | – | 2 | $843K | Jul 1, 2026 |
| Dawn Halkuff | 0 | – | 2 | $431K | Jun 4, 2026 |
| Pieper Steven | 0 | – | 2 | $383K | Jul 7, 2026 |
| John Shannon | 0 | – | 2 | $350K | Jan 5, 2026 |
| Jeffrey W. Sherman | 0 | – | 1 | $335K | Aug 28, 2025 |
| Persky Marla | 0 | – | 2 | $211K | Jun 3, 2026 |
| Barbara-Jean Bormann-Kennedy | 0 | – | 2 | $204K | Jun 4, 2026 |
| Brady James Aloysius | 0 | – | 1 | $60K | Mar 30, 2026 |
5%+ holders
No current 5%+ beneficial-ownership positions on file.
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Steven Pieper | $231K | Jul 7, 2026 | filing ↗ |
| Steven Pieper | $144K | Jul 6, 2026 | filing ↗ |
| Beth Hecht | $396K | Jul 1, 2026 | filing ↗ |
| Kevin McCulloch | $950K | Jul 1, 2026 | filing ↗ |
| Dawn Halkuff | $118K | Jun 4, 2026 | filing ↗ |
| John H Johnson | $88K | Jun 4, 2026 | filing ↗ |
| Barbara-Jean Bormann-Kennedy | $94K | Jun 4, 2026 | filing ↗ |
| Marla Persky | $93K | Jun 3, 2026 | filing ↗ |
| James Brady | $59K | Mar 30, 2026 | filing ↗ |
| Beth Hecht | $408K | Mar 2, 2026 | filing ↗ |
| Kevin McCulloch | $433K | Jan 8, 2026 | filing ↗ |
| John H Johnson | $977K | Dec 19, 2025 | filing ↗ |
| Barbara-Jean A Bormann-Kennedy | $105K | Dec 12, 2025 | filing ↗ |
| John Shannon | $365K | Nov 13, 2025 | filing ↗ |
| Beth Hecht | $515K | Nov 11, 2025 | filing ↗ |
| Marla Persky | $121K | Sep 11, 2025 | filing ↗ |
| Jeffrey Sherman | $335K | Aug 28, 2025 | filing ↗ |
| John H Johnson | $786K | Aug 13, 2025 | filing ↗ |
| Dawn Halkuff | $309K | Aug 12, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Unregistered equity sale (3.02) | Jul 15, 2026 | filing ↗ |
| Other events (8.01) | Jul 15, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jun 29, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 29, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 29, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Jun 10, 2026 | filing ↗ |
| Other events (8.01) | Jun 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 10, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 4, 2026 | filing ↗ |
| Earnings (2.02) | May 7, 2026 | filing ↗ |
| Officer/director changes (5.02) | Apr 20, 2026 | filing ↗ |
| Earnings (2.02) | Mar 2, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 2, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Feb 26, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 26, 2026 | filing ↗ |
| Earnings (2.02) | Jan 8, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Dec 1, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 1, 2025 | filing ↗ |
| Earnings (2.02) | Nov 6, 2025 | filing ↗ |
| Earnings (2.02) | Aug 7, 2025 | filing ↗ |